Equitybee Launches Equity Value Finder to Provide Startup Employees with The Market Value of Stock Options
Palo Alto, California–(Newsfile Corp. – March 29, 2023) – Equitybee, a FinTech company and a…
Palo Alto, California–(Newsfile Corp. – March 29, 2023) – Equitybee, a FinTech company and a…
London, United Kingdom–(Newsfile Corp. – March 29, 2023) – WasteTrade is introducing ThinkCarbon, an AI-powered…
London, United Kingdom–(Newsfile Corp. – March 29, 2023) – WasteTrade is introducing ThinkCarbon, an AI-powered…
LONDON, Mar 29, 2023 – (ACN Newswire) – Tresorfx, a leading global investment firm, is…
The Answer Engine℠ will empower the global sustainability consultancy with faster access to knowledge across…
JAKARTA, Mar 29, 2023 – (ACN Newswire) – NeutraDC, a brand of PT Telkom Data…
NEW YORK, NY, Mar 29, 2023 – (ACN Newswire) – US3R is proud to announce…
Oregon drivers pay less for driving less while also supporting reforestation throughout the state’s Santiam…
Platform uses GPT AI and Qwoted.com data Identifies trending media topics across core financial industries…
Real-time, omni-channel listening and data analytics key to delivering impact on customer experience in financial…
Allows payers and providers to query 500+ terabytes of enriched rates data in seconds SAN…
HAMPTON, N.J., March 29, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
HAMPTON, N.J., March 29, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. (“Lucy” or…
VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. (“Lucy” or…
LOS ANGELES, March 29, 2023 (GLOBE NEWSWIRE) — (NASDAQ: ENOB). Enochian BioSciences Inc. (the “Company”)…
LOS ANGELES, March 29, 2023 (GLOBE NEWSWIRE) — (NASDAQ: ENOB). Enochian BioSciences Inc. (the “Company”)…
DURHAM, N.C., March 29, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
DURHAM, N.C., March 29, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
The BIIB080 Phase 1b clinical study is the first to show a reduction of this…